Impact of Postprostatectomy Prostate-Specific Antigen Nadir on Outcomes Following Salvage Radiotherapy
- 1 June 1998
- Vol. 51 (6) , 998-1002
- https://doi.org/10.1016/s0090-4295(98)00023-5
Abstract
No abstract availableKeywords
This publication has 15 references indexed in Scilit:
- THERAPEUTIC IRRADIATION FOR PATIENTS WITH AN ELEVATED POST-PROSTATECTOMY PROSTATE SPECIFIC ANTIGEN LEVELJournal of Urology, 1997
- Adjuvant and salvage irradiation following radical prostatectomy for prostate cancerInternational Journal of Radiation Oncology*Biology*Physics, 1997
- The Use of Radiotherapy for Patients with Isolated Elevation of Serum Prostate Specific Antigen Following Radical ProstatectomyJournal of Urology, 1996
- Delayed/salvage radiation therapy in patients with elevated prostate specific antigen levels after radical prostatectomy: A long term follow‐upCancer, 1996
- Predicting the need for adjuvant systemic therapy in patients receiving postprostatectomy irradiationUrology, 1996
- Effect of radiation therapy after radical prostatectomy on serum prostate-specific antigen measured by an ultrasensitive assayUrology, 1995
- The efficacy of postprostatectomy radiotherapy in patients with an isolated elevation of serum prostate-specific antigenInternational Journal of Radiation Oncology*Biology*Physics, 1995
- Evaluation of serum prostate-specific antigen velocity after radical prostatectomy to distinguish local recurrence from distant metastasesUrology, 1994
- Serum prostate-specific antigen after post prostatectomy radiotherapyUrology, 1992
- Nonparametric Estimation from Incomplete ObservationsJournal of the American Statistical Association, 1958